UnitedHealth's dip offers long-term value, backed by strong fundamentals, rising dividends, and growth potential. Learn why ...

With a price target of $377, analysts from the Bernstein SocGen Group reiterated their Outperform rating on UnitedHealth ...

A return of a former CEO and questions about its Medicare Advantage pricing dominate the outlook for this formerly ...

UnitedHealth (NYSE: UNH) is struggling to recover investor trust that was eroded when the company missed its earnings expectations. Should you invest $1,000 in UnitedHealth Group right now? Stock ...

UnitedHealth Group’s (UNH) awful spring has scared off many investors, but given its size and inclusion in benchmark indexes ...

UnitedHealth is trying to calm investor nerves with a memo full of optimism and disclaimers. CEO Stephen Hemsley, freshly ...

UnitedHealth Group's UNH short percent of float has risen 25.51% since its last report. The company recently reported that it ...

US insurance behemoth UnitedHealth Group is suing The Guardian for defamation weeks after the British-based newspaper published a salacious investigative report alleging the company intentionally ...

UnitedHealth Group is suing The Guardian for defamation following the publication of an investigative report from the media outlet that accuses the company of engaging in harmful and fraudulent ...

Manhattan prosecutors said that when Luigi Mangione was arrested on a murder charge last year he was carrying a diary that ...

UnitedHealth Group struck a positive note about its acquisition of Amedisys during its annual meeting of shareholders on ...

The stock market has seen a sharp rebound after the declines in the first quarter, so valuations are not as cheap as they once were. However, I am constantly searching for underva ...